Clinical Trial Update: An Study to Determine the Bioavailability of E2609 Tablets Compared to Capsules and the Effect of Food on Absorption [Phase 1]

View source ↗

Summary

Phase 1 trial comparing the bioavailability of E2609 tablets to capsules and assessing the effect of food on absorption in Alzheimer's disease; the study has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• E2609

Snippet

Sponsor: Eisai Inc. | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED